Arvinas (ARVN)
Develops PROTAC degraders around VEPPANU and clinical oncology, neurology, and neuromuscular programs.
$8.44
vs last close−0.07 (−0.82%)
Something off on this page? Send us feedback.
Next report
Nov 4, 26
in 42 days
EPS estimate
−$0.87
Revenue estimate
$16.8M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported−$0.63$1.14−$0.84−$0.48−$1.10−$0.90$2.58Pending
Estimate−$1.07−$0.86−$0.87−$0.75−$0.55−$0.95−$0.37−$0.87
Surprise+41.1%+232.6%+3.4%+36.0%−100.0%+5.3%+789.6%—
RevenueReportedEstimate
Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported$59.2M$188.8M$22.4M$41.9M$9.5M$15.6M$249.7MPending
Estimate$42.5M$42.3M$25.0M$37.3M$37.2M$16.6M$60.7M$16.8M
Surprise+39.2%+346.3%−10.4%+12.4%−74.5%−6.1%+311.3%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | −$0.82 | — | — |
| Sep 2027 | −$0.87 | — | — |
| Jun 2027 | −$0.93 | — | — |
| Mar 2027 | −$0.93 | — | — |
| Dec 2026 | −$0.87 | — | — |
| Nov 2026 | −$0.87 | — | — |
| Aug 2026 | −$0.37 | $2.58 | +789.6% |
| May 2026 | −$0.95 | −$0.90 | +5.3% |
| Feb 2026 | −$0.55 | −$1.10 | −100.0% |
| Nov 2025 | −$0.75 | −$0.48 | +36.0% |
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Oct 2024 | |||
| Jul 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| Apr 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Nov 2018 | |||
| Jun 2018 | |||
| Sep 2018 | |||
| Dec 2017 | |||
| Sep 2017 | |||
| Jun 2017 | |||
| Mar 2017 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | −$0.82 | — | — | $22.3M | — | — | — |
| Sep 2027 | −$0.87 | — | — | $18.5M | — | — | — |
| Jun 2027 | −$0.93 | — | — | $15.3M | — | — | — |
| Mar 2027 | −$0.93 | — | — | $15.0M | — | — | — |
| Dec 2026 | −$0.87 | — | — | $15.5M | — | — | — |
| Nov 4, 2026 | −$0.87 | — | — | $16.8M | — | — | — |
| Aug 4, 2026 | −$0.37 | $2.58 | +789.6% | $60.7M | $249.7M | +311.3% | +11.7% |
| May 12, 2026 | −$0.95 | −$0.90 | +5.3% | $16.6M | $15.6M | −6.1% | −0.9% |
| Feb 24, 2026 | −$0.55 | −$1.10 | −100.0% | $37.2M | $9.5M | −74.5% | +0.6% |
| Nov 5, 2025 | −$0.75 | −$0.48 | +36.0% | $37.3M | $41.9M | +12.4% | +0.3% |
| Aug 6, 2025 | |||||||
| May 1, 2025 | |||||||
| Feb 11, 2025 | |||||||
| Oct 30, 2024 | |||||||
| Jul 30, 2024 | |||||||
| May 7, 2024 | |||||||
| Feb 27, 2024 | |||||||
| Nov 7, 2023 | |||||||
| Aug 8, 2023 | |||||||
| May 5, 2023 | |||||||
| Feb 23, 2023 | |||||||
| Nov 8, 2022 | |||||||
| Aug 4, 2022 | |||||||
| May 5, 2022 | |||||||
| Feb 28, 2022 | |||||||
| Nov 3, 2021 | |||||||
| Aug 5, 2021 | |||||||
| May 4, 2021 | |||||||
| Mar 1, 2021 | |||||||
| Nov 5, 2020 | |||||||
| Aug 4, 2020 | |||||||
| Apr 28, 2020 | |||||||
| Mar 16, 2020 | |||||||
| Nov 4, 2019 | |||||||
| Aug 5, 2019 | |||||||
| May 8, 2019 | |||||||
| Mar 26, 2019 | |||||||
| Nov 14, 2018 | |||||||
| Jun 30, 2018 | |||||||
| Sep 27, 2018 | |||||||
| Dec 31, 2017 | |||||||
| Sep 30, 2017 | |||||||
| Jun 30, 2017 | |||||||
| Mar 31, 2017 |